Merck Co MRK Q1 2026 Earnings Oncology Momentum Pipeline Milestones and Raised Guidance Signal Balanced NearTerm and LongTerm Prospects How Ibotta IBTA thinks about risk management Ibotta posts 292 negative EPS miss well below estimates RNA Atrium Therapeutics revenue surges 708 in Q1 but shares slip as losses persist Why LightWave LWAC ability to execute stands out 010 20260508 RBC Capital Upgrades Price Target for Banco Santander Amid Positive Outlook Iran Strikes Test Wall Street Optimism as Deal Talks Continue Broad Market Gains as Healthcare and Tech Lead Communication Services Slips Estate Transparency Concerns Family Dispute Highlights Risks of Unsupervised Asset Control Gold Investment Strategies for 2026 Analyzing Ownership Options Indian Stock Markets Shut for Bakri Id Asian Peers Dip on Crude Oil Worries